drug
FENOFIBRATE
Marketedupdated 3mo agoby Orit Laboratories LLC
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 8- tagApproval54 co-mentions · 27 sources
- drugANTARA (MICRONIZED)47 co-mentions · 29 sources
- drugAntara47 co-mentions · 29 sources
- drugFenoglide29 co-mentions · 29 sources
- tagSmall Molecule27 co-mentions · 27 sources
- drugFENOFIBRIC ACID16 co-mentions · 8 sources
- drugcholine fenofibrate DR16 co-mentions · 8 sources
- drugcholine fenofibrate8 co-mentions · 8 sources
indications
investigational
Hyperlipidemia
all catalysts(19)
approval · 19
Nov 30, 2004
approval
ANTARA (MICRONIZED) (FENOFIBRATE) — FDA approval
FENOFIBRATE
→
Oct 21, 2005
approval
ANTARA (MICRONIZED) (FENOFIBRATE) — FDA approval
FENOFIBRATE
→
Jun 3, 2008
approval
ANTARA (MICRONIZED) (FENOFIBRATE) — FDA approval
FENOFIBRATE
→
Mar 1, 2012
approval
ANTARA (MICRONIZED) (FENOFIBRATE) — FDA approval
FENOFIBRATE
→
Dec 19, 2012
approval
ANTARA (MICRONIZED) (FENOFIBRATE) — FDA approval
FENOFIBRATE
→
Oct 18, 2013
approval
ANTARA (MICRONIZED) (FENOFIBRATE) — FDA approval
FENOFIBRATE
→
Sep 4, 2014
approval
ANTARA (MICRONIZED) (FENOFIBRATE) — FDA approval
FENOFIBRATE
→
Aug 31, 2015
approval
ANTARA (MICRONIZED) (FENOFIBRATE) — FDA approval
FENOFIBRATE
→
Nov 9, 2016
approval
ANTARA (MICRONIZED) (FENOFIBRATE) — FDA approval
FENOFIBRATE
→
Nov 29, 2016
approval
ANTARA (MICRONIZED) (FENOFIBRATE) — FDA approval
FENOFIBRATE
→
Sep 11, 2017
approval
ANTARA (MICRONIZED) (FENOFIBRATE) — FDA approval
FENOFIBRATE
→
May 18, 2018
approval
ANTARA (MICRONIZED) (FENOFIBRATE) — FDA approval
FENOFIBRATE
→
Nov 7, 2018
approval
ANTARA (MICRONIZED) (FENOFIBRATE) — FDA approval
FENOFIBRATE
→
Feb 4, 2019
approval
ANTARA (MICRONIZED) (FENOFIBRATE) — FDA approval
FENOFIBRATE
→
May 15, 2019
approval
ANTARA (MICRONIZED) (FENOFIBRATE) — FDA approval
FENOFIBRATE
→
Jun 3, 2021
approval
ANTARA (MICRONIZED) (FENOFIBRATE) — FDA approval
FENOFIBRATE
→
Jul 30, 2024
approval
ANTARA (MICRONIZED) (FENOFIBRATE) — FDA approval
FENOFIBRATE
→
Oct 1, 2025
approval
ANTARA (MICRONIZED) (FENOFIBRATE) — FDA approval
FENOFIBRATE
→
Jan 21, 2026
approval
FENOFIBRATE — FDA approval
FENOFIBRATE
→
Trials studying FENOFIBRATE
- phase3The Fenofibrate And Microvascular Events in Type 1 Diabetes Eye.
- phase3Fenofibrate for Prevention of DR Worsening
- —Lipoprotein(a) Levels in Patients With Atherosclerotic Cardiovascular Diseases in Russia
- phase3A Phase 3 Study to Evaluate the Efficacy and Safety of K-877 in Chinese Patients With High TG and Low HDL-C
- phase3Study of Ezetimibe and Fenofibrate in Patients With Mixed Hyperlipidemia (0653-036)(COMPLETED)
- phase3Two Investigational Drugs in Patients With Mixed Hyperlipidemia (0653-036)
- phase4Choline Fenofibrate and Carotid Atherosclerosis in Patients With Type 2 Diabetes and Combined Dyslipidemia
Patent cliff
source: FDA Orange Bookfirst barrier falls
May 31, 2033
~6.8 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (1)
- May 31, 2033formulationUS 9314447
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 7m ago
Found something off?
comments(0)
5-min edit window · permanent after that